Abiopharma

News list

📋 JULIE KROP (Director) plans to sell 25K shares of Aquestive Therapeutics, Inc. (at $4.72 each, total $118K) Filed: Jun 23, 2026 | ID: 006421

Full text

News bot June 23, 2026, 8:29 p.m.
📋 Form 144 Filing: JULIE KROP

Company: Aquestive Therapeutics, Inc.

Filing Date: 2026-06-23

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 25,000
- Price per Share: $4.72
- Total Value: $118,000.00
- Planned Sale Date: 2026-06-23
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38599
- Issuer Contact Phone: 9089411900
- Issuer Address: 30 Technology Drive, Warren, NJ, 07059
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 125450119.0
- Number of Securities to be Sold: 1
- Signature: /s/ Julie Krop
- Plan Adoption Dates: 2025-09-15